These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Author: Haas CD, Lehane D, Bottomley R.
    Journal: Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328.
    Abstract:
    A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No drug deaths or life-threatening toxicity were reported. Further evaluation of DAG in thyroid tumors is warranted.
    [Abstract] [Full Text] [Related] [New Search]